Royal Children's Hospital, Melbourne, Melbourne, VIC.
Murdoch Children's Research Institute, Melbourne, VIC.
Med J Aust. 2023 Jun 5;218(10):460-466. doi: 10.5694/mja2.51934. Epub 2023 Apr 22.
To examine the clinical characteristics and short term outcomes for children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections who presented to Australian hospitals during 2020 and 2021.
DESIGN, SETTING: Retrospective case review study in nineteen hospitals of the Paediatric Research in Emergency Departments International Collaborative (PREDICT) network from all Australian states and territories, including seven major paediatric tertiary centres and eight Victorian hospitals.
SARS-CoV-2-positive people under 18 years of age who attended emergency departments or were admitted to hospital during 1 February 2020 - 31 December 2021.
Epidemiological and clinical characteristics, by hospital care type (emergency department [ED] or inpatient care).
A total of 1193 SARS-CoV-2-positive children and adolescents (527 girls, 44%) attended the participating hospitals (107 in 2020, 1086 in 2021). Their median age was 3.8 years (interquartile range [IQR], 0.8-11.4 years); 63 were Aboriginal or Torres Strait Islander people (5%). Other medical conditions were recorded for 293 children (25%), including asthma (86, 7%) and premature birth (68, 6%). Medical interventions were not required during 795 of 1181 ED presentations (67%); children were discharged directly home in 764 cases (65%) and admitted to hospital in 282 (24%; sixteen to intensive care units). The 384 admissions to hospital (including 102 direct admissions) of 341 children (25 infants under one month of age) included 23 to intensive care (6%); the median length of stay was three days (IQR, 1-9 days). Medical interventions were not required during 261 admissions (68%); 44 children received respiratory support (11%) and 21 COVID-19-specific treatments, including antiviral and biologic agents (5%). Being under three months of age (v one year to less than six years: odds ratio [OR], 2.6; 95% confidence interval [CI], 1.7-4.0) and pre-existing medical conditions (OR, 2.5; 95% CI, 1.9-3.2) were the major predictors of hospital admission. Two children died, including one without a known pre-existing medical condition.
During 2020 and 2021, most SARS-CoV-2-positive children and adolescents who presented to participating hospitals could be managed as outpatients. Outcomes were generally good, including for those admitted to hospital.
研究 2020 年至 2021 年期间在澳大利亚医院就诊的严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染儿童的临床特征和短期结局。
设计、地点:来自澳大利亚所有州和地区的儿科急诊研究国际协作(PREDICT)网络的 19 家医院的回顾性病例研究,包括 7 家主要儿科三级中心和 8 家维多利亚州医院。
2020 年 2 月 1 日至 2021 年 12 月 31 日期间因 SARS-CoV-2 阳性而在急诊部门就诊或住院的 18 岁以下人群。
按医院护理类型(急诊或住院治疗)的流行病学和临床特征。
共有 1193 名 SARS-CoV-2 阳性儿童和青少年(527 名女孩,44%)在参与医院就诊(2020 年 107 例,2021 年 1086 例)。他们的中位年龄为 3.8 岁(四分位距 [IQR],0.8-11.4 岁);63 人为原住民或托雷斯海峡岛民(5%)。293 名儿童(25%)有其他医疗状况,包括哮喘(86 例,7%)和早产(68 例,6%)。在 1181 例急诊科就诊中有 795 例(67%)无需医疗干预;764 例(65%)直接出院回家,282 例(24%;16 例入住重症监护病房)入院。341 名儿童(包括 102 名直接入院)中,384 名(包括 25 名 1 个月以下婴儿)住院,其中 23 名(6%)入住重症监护病房;中位住院时间为 3 天(IQR,1-9 天)。在 261 例(68%)入院中无需医疗干预;44 名儿童接受呼吸支持(11%)和 21 种 COVID-19 特异性治疗,包括抗病毒和生物制剂(5%)。年龄小于 3 个月(与 1 岁至 6 岁以下相比:比值比 [OR],2.6;95%置信区间 [CI],1.7-4.0)和预先存在的医疗条件(OR,2.5;95%CI,1.9-3.2)是住院的主要预测因素。有 2 名儿童死亡,其中 1 名无已知预先存在的医疗条件。
2020 年至 2021 年期间,在参与医院就诊的大多数 SARS-CoV-2 阳性儿童和青少年可作为门诊患者进行管理。结果总体良好,包括住院患者。